Search research articles
Contact Us
Filters
Showing results (31-40 of 284) with videos related to
Page
of 29
Sort By:
Journal of Clinical Pharmacology
|
February 8, 2019
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C Michael White
Journal of Clinical Pharmacology
|
September 10, 2016
The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids
C Michael White
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 20, 2017
Pharmacologic and clinical assessment of kratom
C Michael White
The Annals of Pharmacotherapy
|
September 30, 2021
Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate Drugs
C Michael White
The Annals of Pharmacotherapy
|
October 17, 2019
Generic Drugs Not as Safe as FDA Wants You to Believe
C Michael White
Cardiac Electrophysiology Review
|
November 18, 2003
Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST)
Jeffrey Kluger, C Michael White
Connecticut Medicine
|
August 30, 2006
The use of intravenous amiodarone for chemical conversion of atrial fibrillation
Krista Dale, C Michael White
Connecticut Medicine
|
January 1, 2005
Adjunctive intravenous magnesium to reduce toxicity and enhance efficacy of class III antiarrhythmic agents
Nickole Henyan, C Michael White
Connecticut Medicine
|
March 23, 2005
The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation
Stephen Sander, C Michael White
The Annals of Pharmacotherapy
|
October 21, 2016
Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation
C Michael White, Elaine Nguyen
Page
of 29
Search research articles
Search
Showing results (31-40 of 284) with videos related to
Sort By:
Page
of 29
Journal of Clinical Pharmacology
|
February 8, 2019
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C Michael White
Journal of Clinical Pharmacology
|
September 10, 2016
The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids
C Michael White
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 20, 2017
Pharmacologic and clinical assessment of kratom
C Michael White
The Annals of Pharmacotherapy
|
September 30, 2021
Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate Drugs
C Michael White
The Annals of Pharmacotherapy
|
October 17, 2019
Generic Drugs Not as Safe as FDA Wants You to Believe
C Michael White
Cardiac Electrophysiology Review
|
November 18, 2003
Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST)
Jeffrey Kluger, C Michael White
Connecticut Medicine
|
August 30, 2006
The use of intravenous amiodarone for chemical conversion of atrial fibrillation
Krista Dale, C Michael White
Connecticut Medicine
|
January 1, 2005
Adjunctive intravenous magnesium to reduce toxicity and enhance efficacy of class III antiarrhythmic agents
Nickole Henyan, C Michael White
Connecticut Medicine
|
March 23, 2005
The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation
Stephen Sander, C Michael White
The Annals of Pharmacotherapy
|
October 21, 2016
Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation
C Michael White, Elaine Nguyen
Page
of 29